PCN86 DRUG UTILIZATION AND COST CONSIDERATIONS OF ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
May 1, 2008, 00:00
10.1016/S1098-3015(10)70262-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)70262-X/fulltext
Title :
PCN86 DRUG UTILIZATION AND COST CONSIDERATIONS OF ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70262-X&doi=10.1016/S1098-3015(10)70262-X
First page :
Section Title :
Open access? :
No
Section Order :
916